Associate Principal - Financial Institutions Consulting - Europe

IQVIA’s Financial Institutions Consulting (FIC) team advises investors (e.g. private equity, venture capital, hedge funds, etc.) on biopharma and life sciences investments, including commercial due diligence, asset and target screening, portfolio company growth strategy and exit/divestment strategy. Successful candidates will have the opportunity to engage with clients on high-profile investment decisions across a variety of industry-shaping transaction situations, business models and strategic issues. We operate in a multi-cultural, collaborative and fast-paced work environment, that is rich in development and growth.

As a Manager within IQVIA’s FIC team, you will be responsible for managing projects primarily in the areas of due diligence (buy- and sell-side), asset/portfolio/company valuation, asset screening and growth strategy.

• Leverage consulting and transaction advisory experience, IQVIA information and expertise, and methodological know-how to manage projects that address client/business questions.
• Diagnose and understand complex strategic issues/diligence questions and structure project approach and team setup to address engagement objectives.
• Manage project teams on a day-to-day basis through guiding research approaches, the design, development and delivery of client reports and presentations and QC of deliverables.
• Serve as day-to-day point of contact with clients during project delivery – including presenting/communicating key project insights and recommendations – ensuring engagement satisfaction and supporting long-term enhancement of client relationships.
• Contribute to overall FIC team capabilities, including (but not limited to) the development of intellectual property, marketing materials, training, recruitment and go-to-market approach.
• Support Principals with business development, including proposal development and presentations.
• Serve as development lead of 3-4 team members, alongside supporting broader team development.

Candidates interested in joining IQVIA FIC as a Manager should have:

• Minimum of 5-6 years professional experience in strategy consulting, M&A/BDL roles or within a financial institution (e.g. private equity, venture capital).
• Experience advising clients on commercial issues in the biopharma/life sciences industry and/or financial investors, including exposure to projects related to transactions/investments (due diligence, valuation, asset identification, growth strategy, forecasting).
• Project management experience in relevant domains, including managing large, multi-disciplined teams while maintaining high quality delivery.
• Demonstrated skills including project planning, workstream oversight, presentation/report development, quality control and client engagement.
• Strong quantitative/analytical and qualitative research experience, supported by a problem solving mentality, keen eye for detail and critical thinking.
• Comfortable interpreting commercial/financial trends and results, with ability to guide teams to design and execute research and analysis and translate outputs into strategic implications for investors.
• Well-developed written and verbal communication skills including presentations, chairing meetings/Q&A sessions and report writing.
• Knowledge of key issues and current developments in the biopharma/life sciences industry.
• Evidence of career progression in consulting and/or transaction advisory roles.

In addition to the skills and experience above, a Manager should have:

• Bachelor’s degree or equivalent. MBA not required but a plus.
• A track record of leadership and people development.
• Fluency in English (spoken and written).
• A willingness and ability to travel (where required).
• Right to live and work in the recruiting country.

IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.